At the 2024 Telstra Best of Business Awards in February, Earworx was recognised as the National Championing Health Award winner. Lisa Hellwege, the Clinical Director and Founder of Earworx, expressed her gratitude to the entire team and their patients for their trust and support. Earworx specialises in providing professional earwax removal services led by trained nurses using a procedure called microsuction.
Having identified a gap in the market for safe and gentle earwax removal services in her local community, Lisa started Earworx as a part-time venture alongside her role at the Royal Hobart Hospital. Over time, the business grew, and she transitioned to running it full-time, overcoming various challenges along the way, including the impact of COVID-19 and navigating the regulatory environment.
The recognition received at the Telstra Best of Business Award was a meaningful validation of Earworx’s efforts. It not only bolstered the business’s already strong reputation but also provided a boost to its branding, according to Hellwege.
Describing the rigorous application process, including extensive submissions and nerve-wracking presentations, Hellwege acknowledged that it provided invaluable insights into their own business.
Looking ahead, Earworx aims to raise awareness about the vital role of registered nurses in supporting the Australian healthcare system and addressing its challenges. The business plans to continue its mission of delivering high-quality, nurse-led earwax removal services while advocating for recognition and support from funding bodies.
-
Impact of genetic pathologist role across medicine
Dr Marina Berbic is a genetic pathologist and the Deputy Director of Genetics at Douglass Hanly Moir Pathology – a laboratory based in Sydney and part of Sonic Healthcare. The genetics department at Douglass Hanly Moir offers a wider array of genetic tests across many domains, and the medical leadership model ensures the highest possible standard of care and commitment to patient safety.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
-
Clinical trial site in primary care setting open for novel therapies in psychiatry
Over the past decade, Paratus has been involved in over 200 clinical trials across 4 clinical site locations. Now a fifth site, the newly opened Melbourne site will cater to both primary care and psychiatry, specifically designed for psychedelic studies.
The new Melbourne site will be a focused on primary care studies specifically expanding access to psychiatric research, a growing area of unmet need. Australian Health Journal met with 3 recent hires brought in to support clinical trials across the organisation and in psychiatry in Melbourne.
